Skip to main content
. 2004 Sep;15(9):4179–4190. doi: 10.1091/mbc.E04-03-0181

Table 2.

Oligonucleotide primers used in this study

Oligonucleotide Sequence 5′-3′
HOGdelF caccaatagatacactgagctaaatcccgtgggaatgggagcatttggtttggtgtgctcagccgttgatagattaactgccagggttttcccagtcacg
HOGdelR gccacaccaacagtttgatgaaagtctaaaatttcactgtacatcataactctccaagtatccactggcaagtctgcgtcctcactaaagggaacaaaagc
HOG1PstF aatgtctgcagatggagaatttacaagaacc
HOG1PromF gcgcggatccgacatttccgttaaagtgtccac
HOG1TermR gcgcggatccggggaaacagtgaatatgtaaaatgtg
HOG1HMR gaattcgctagcttaatgatggtgatgatggtgtaagtcctcctcgctgatcaaatttttgttcttcagccatggacaaatcttcttcagaaattaacttttgctcctcagctccgttggcggaatccaag
HOG1YFPF aatgaaactgagggttccgaacaaccagacctgcaagtggagcaaaacaacttggattccgccaacggagctggtggtggttctaaaggtgaagaattatt
HOG1YFPR gttaatagtaatagtaatacatatttcacttttaaatttatttctataattgctagcttgtatttttgaagctctagaaggaccacctttgattg
HOG1BamF gcgcggatcccatgtctgcagatggagaatttacaagaacc
HOG1BamR gcgcggatccttaagctccgttggcggaatcc
HSP12-F atgtctgacgccggaag
HSP12-R agtactatcagcgccgg
RHR2-F gacaaagactcaacaaccag
PHR2-R ccttgaattcgtcagtttcc
ACT1-F gatgaagcccaatccaaaag
ACT1-R ggagttgaaagtggtttggt